Delivering actionable strategic insights and deal support as our clients navigate the increasingly complex Precision Medicine ecosystem
Precision Medicine is fundamentally changing the healthcare and lab ecosystems. While hospitals grapple with how to leverage the vast data sets at their disposal to inform better clinical decision making, commercial and hospital labs are seeking partnerships with diagnostics and biopharma companies for access to data and technological innovations that can help drive top and bottom line growth. KPMG is helping clients navigate this complexity through clear strategic and operational guidance, combined with a full suite of deal services as we help our clients achieve scale and competitive advantage through M&A.
Biopharma business growth acceleration for a leading academic medical center
Download PDFBuilding up COVID-19 testing capabilities
Download PDFGlobal opportunity assessment for a leading academic medical center
Download PDFBiopharma Companies
Supporting the biopharma industry as it is develops and launches the most cutting edge innovation in Precision Medicine
Diagnostic & Life Science Tools Companies
Supporting our diagnostic and life science tools clients as they reshape their businesses to be future leaders in Precision Medicine
Private Investors
Offering deal and non-deal services to our private investors as they look for opportunities in the Precision Medicine market
Industry insights and trends, one click away.